These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8749727)

  • 1. Key ingredients to effective addictions treatment.
    Waltman D
    J Subst Abuse Treat; 1995; 12(6):429-39. PubMed ID: 8749727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs.
    Kim S; McLeod JH; Williams C; Hepler N
    J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction effects of client and treatment program characteristics on retention: an exploratory analysis using hierarchical linear models.
    Chou CP; Hser YI; Anglin MD
    Subst Use Misuse; 1998 Sep; 33(11):2281-301. PubMed ID: 9758014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies.
    Greenfield L; Burgdorf K; Chen X; Porowski A; Roberts T; Herrell J
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):537-50. PubMed ID: 15540492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed and dynamic predictors of client retention in therapeutic communities.
    Condelli WS; De Leon G
    J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic communities for addictions: a theoretical framework.
    De Leon G
    Int J Addict; 1995; 30(12):1603-45. PubMed ID: 8557410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theory-based active ingredients of effective treatments for substance use disorders.
    Moos RH
    Drug Alcohol Depend; 2007 May; 88(2-3):109-21. PubMed ID: 17129682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians.
    Rosenberg H; Davis AK
    J Subst Abuse Treat; 2014 Feb; 46(2):214-8. PubMed ID: 23953169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Program characteristics for successful treatment of adolescent drug abuse.
    Friedman AS; Glickman NW
    J Nerv Ment Dis; 1986 Nov; 174(11):669-79. PubMed ID: 3772356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical characteristics of residential psychiatric and substance abuse programs: organizational determinants and patients outcomes.
    Timko C
    Am J Community Psychol; 1996 Feb; 24(1):173-92. PubMed ID: 8712185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SWEDATE Project: interaction between treatment, client background, and outcome in a one-year follow-up.
    Berglund GW; Bergmark A; Björling B; Grönbladh L; Lindberg S; Oscarsson L; Olsson B; Segraeus V; Stensmo C
    J Subst Abuse Treat; 1991; 8(3):161-9. PubMed ID: 1660080
    [No Abstract]   [Full Text] [Related]  

  • 12. Barriers and Facilitators to Substance Use Treatment in the Rural South: A Qualitative Study.
    Browne T; Priester MA; Clone S; Iachini A; DeHart D; Hock R
    J Rural Health; 2016; 32(1):92-101. PubMed ID: 26184098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapting the chronic disease model in the treatment of dually diagnosed patients.
    Johnson RA
    J Subst Abuse Treat; 1992; 9(1):63-70. PubMed ID: 1317467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addictive disorders in context: principles and puzzles of effective treatment and recovery.
    Moos RH
    Psychol Addict Behav; 2003 Mar; 17(1):3-12. PubMed ID: 12665076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Initial Evaluation of a Comprehensive Continuing Care Intervention for Clients with Substance Use Disorders: My First Year of Recovery (MyFYR).
    McKay JR; Knepper C; Deneke E; O'Reilly C; DuPont RL
    J Subst Abuse Treat; 2016 Aug; 67():50-4. PubMed ID: 27296662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding results from randomized trials: use of program- and client-level data to study medical and nonmedical treatment programs.
    Kaskutas LA; Ammon L; Witbrodt J; Graves K; Zemore S; Borkman T; Weisner S
    J Stud Alcohol; 2005 Sep; 66(5):682-7. PubMed ID: 16331853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who cares for involuntary clients?
    Soliman S; Pollack HA; Alexander JA
    Subst Abus; 2009; 30(1):1-13. PubMed ID: 19197777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stage of change approach to addiction in the medical setting.
    Peteet JR; Brenner S; Curtiss D; Ferrigno M; Kauffman J
    Gen Hosp Psychiatry; 1998 Sep; 20(5):267-73. PubMed ID: 9788026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reenvisioning success for programs supporting pregnant women with problematic substance use.
    Marcellus L; MacKinnon K; Benoit C; Phillips R; Stengel C
    Qual Health Res; 2015 Apr; 25(4):500-12. PubMed ID: 25258337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment dependence: preliminary description of yet another syndrome.
    Bell J
    Br J Addict; 1992 Jul; 87(7):1049-54. PubMed ID: 1643398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.